Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma.
about
Antibodies as therapeutic agents: vive la renaissance!Homing and mobilization of hematopoietic stem cells and hematopoietic cancer cells are mirror image processes, utilizing similar signaling pathways and occurring concurrently: circulating cancer cells constitute an ideal target for concurrent treatmStem cell transplantation for mantle cell lymphoma: if, when and how?
P2860
Safety and feasibility of CHOP/rituximab induction treatment followed by high-dose chemo/radiotherapy and autologous PBSC-transplantation in patients with previously untreated mantle cell or indolent B-cell-non-Hodgkin's lymphoma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Safety and feasibility of CHOP ...... B-cell-non-Hodgkin's lymphoma.
@en
Safety and feasibility of CHOP ...... B-cell-non-Hodgkin's lymphoma.
@nl
type
label
Safety and feasibility of CHOP ...... B-cell-non-Hodgkin's lymphoma.
@en
Safety and feasibility of CHOP ...... B-cell-non-Hodgkin's lymphoma.
@nl
prefLabel
Safety and feasibility of CHOP ...... B-cell-non-Hodgkin's lymphoma.
@en
Safety and feasibility of CHOP ...... B-cell-non-Hodgkin's lymphoma.
@nl
P2093
P2860
P356
P1476
Safety and feasibility of CHOP ...... B-cell-non-Hodgkin's lymphoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BMT.1703925
P407
P577
2003-05-01T00:00:00Z
P5875
P6179
1037724933